While the general anti-obesity potential of Ɛ-viniferin has been explored in previous studies [44], its specific role as pancreatic lipase (PL) inhibitors remains relatively under-investigated. The gene discussed is PNLIP; the disease is obesity due to melanocortin 4 receptor deficiency.